Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot: C9BC Exp. 31OCT2022
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- PAI Holdings, LLC. dba Pharmaceutical Associates Inc
- Reason for Recall:
- Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16
Product Codes/Lot Numbers:
Lot: C9BC Exp. 31OCT2022
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-0723-2021
Related Recalls
Class I - Dangerous
Superpotent; sodium benzoate preservative
Cimetidine Hydrochloride Oral Solution 300 mg/5 mL, 8 fl oz (237 mL) Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0649-08
PAI Holdings, LLC.
Class I - Dangerous
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.
Class I - Dangerous
Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.